Monophenol Monooxygenase: Clinical Trials

5 trials of Monophenol Monooxygenase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown. 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Unknown 1
Phase 12Completed 2

Follow Monophenol Monooxygenase: new trials by email Literature Review of Monophenol Monooxygenase trials Research Report on Monophenol Monooxygenase

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dendritic Cell Vaccination During Lymphoid Reconstruction
Autologous Dendritic Cells (DC), Fludarabine, Autologous Lymphocyte Infusion (ALI) - Intraocular Melanoma, Melanoma (Skin)
Phase 1CompletedH. Lee Moffitt Cancer Center and Research Institute182006-02-012014-02-21
Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma
ipilimumab, Tyrosinase/gp100/MART-1 Peptides - Intraocular Melanoma, Melanoma (Skin)
Phase 2CompletedBristol-Myers Squibb772004-05-312022-04-14
Multiepitope Peptide Vaccination in Melanoma
Tyrosinase, MAGE-3, GnTV - Metastatic Melanoma
Phase 2UnknownCharite University, Berlin, Germany252003-03-012010-05-26
Novel Adjuvants for Peptide-Based Melanoma Vaccines
MDX-CTLA4 Antibody; Tyrosinase/gp100/MART-1 Peptides Melanoma Vaccine - Melanoma
Phase 1CompletedUniversity of Southern California192001-08-012014-05-22
Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase
Immunodominant peptides from three melanoma antigens, MART-1, GP100 and tyrosinase - Melanoma, Neoplasm Metastasis
Phase 2CompletedNational Cancer Institute (NCI)1141997-11-012008-03-04

Conditions studied

Melanoma (5)  ·  Neoplasms (2)  ·  Uveal Melanoma (2)  ·  Diabetes Mellitus, Insulin-Dependent, 12 (1)  ·  Neoplasm Metastasis (1)

Sponsors

Bristol-Myers Squibb (1)  ·  Charite University, Berlin, Germany (1)  ·  H. Lee Moffitt Cancer Center and Research Institute (1)  ·  National Cancer Institute (NCI) (1)  ·  University of Southern California (1)

Countries

United States (4)  ·  Germany (1)

Top investigators

Jeffrey S. Weber, M.D., Ph.D. (2)  ·  Ulrich Keilholz, MD (1)

Results publications

PMID 21106722, PMID 32161584

NIH funding

P30CA014089 (1), P30CA076292 (1)